A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/42 (2006.01) A61K 31/44 (2006.01) A61P 25/02 (2006.01)
Patent
CA 2690087
The invention provides methods for treating and/or preventing neuropathic pain by administering to patients therapeutically effective amounts of AMPA receptor antagonists and zonisamide. The neuropathic pain may be diabetic neuropathy. The invention also provides kits, and pharmaceutical compositions comprising therapeutically effective amounts of AMPA receptor antagonists and zonisamide. The AMPA receptor antagonist may be, for example, 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-di-- hydropyridin-2-one.
L'invention concerne des méthodes de traitement et/ou de prévention de la douleur neuropathique par administration de quantités thérapeutiquement efficaces d'antagonistes des récepteurs AMPA et de zonisamide. La douleur neuropathique peut être une neuropathie diabétique. L'invention concerne également des trousses, ainsi que des compositions pharmaceutiques comprenant des quantités thérapeutiquement efficaces d'antagonistes des récepteurs AMPA et de zonisamide. L'antagoniste des récepteurs AMPA peut être, par exemple, la 3-(2-cyanophényl)-5-(2-pyridyl)-1-phényl-1,2-dihydropyridin-2-one.
Eisai R. & D. Management Co. Ltd.
Fetherstonhaugh & Co.
LandOfFree
Ampa receptor antagonists and zonisamide for neuropathic pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ampa receptor antagonists and zonisamide for neuropathic pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ampa receptor antagonists and zonisamide for neuropathic pain will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1934067